Singhe Hospitals Income Statement

Financials in millions LKR. Fiscal year is April - March.

Millions LKR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	1,852	1,507	1,272	1,072	1,002	700.34
Revenue Growth (YoY)	30.84%	18.42%	18.72%	6.99%	43.03%	4.27%
Cost of Revenue	613.87	521.15	507.42	461.08	452.89	269.16
Gross Profit	1,238	985.52	764.89	610.62	548.81	431.18
Selling, General & Admin	899.06	802.8	676.82	531.61	499.46	398.75
Other Operating Expenses	40.81	-1.12	-0.33	-0.67	-0.67	-0.15
Operating Expenses	939.87	801.68	676.49	530.94	498.79	398.6
Operating Income	298.16	183.84	88.4	79.68	50.02	32.58
Interest Expense	-22.95	-30.38	-55.14	-61.57	-33.9	-25.92
Interest & Investment Income	2.7	2.7	1.5	1.11	0.01	0.02
Other Non Operating Income (Expenses)	-7.02	-9.19	-2.27	-3.28	-1.98	-0.88
EBT Excluding Unusual Items	270.89	146.97	32.49	15.94	14.14	5.8
Gain (Loss) on Sale of Investments	-0	-0	-0	0.01	0	0.01
Pretax Income	270.89	146.97	32.49	15.95	14.14	5.8
Income Tax Expense	39.98	30.79	7.86	28.67	-2.27	3.5
Net Income	230.91	116.18	24.63	-12.73	16.41	2.3
Net Income to Common	230.91	116.18	24.63	-12.73	16.41	2.3
Net Income Growth	130.68%	371.73%	-	-	613.87%	-
Shares Outstanding (Basic)	424	431	431	431	431	431
Shares Outstanding (Diluted)	424	431	431	431	431	431
Shares Change (YoY)	1.99%	-	-	-	-	-
EPS (Basic)	0.54	0.27	0.06	-0.03	0.04	0.01
EPS (Diluted)	0.54	0.27	0.06	-0.03	0.04	0.01
EPS Growth	126.18%	371.74%	-	-	613.96%	-
Free Cash Flow	141.7	161.44	75.16	75.13	39.32	1.44
Free Cash Flow Per Share	0.33	0.37	0.17	0.17	0.09	0.00
Gross Margin	66.85%	65.41%	60.12%	56.98%	54.79%	61.57%
Operating Margin	16.10%	12.20%	6.95%	7.43%	4.99%	4.65%
Profit Margin	12.47%	7.71%	1.94%	-1.19%	1.64%	0.33%
Free Cash Flow Margin	7.65%	10.71%	5.91%	7.01%	3.92%	0.21%
EBITDA	361.43	240.79	135.99	134.69	127.17	101.97
EBITDA Margin	19.52%	15.98%	10.69%	12.57%	12.70%	14.56%
D&A For EBITDA	63.27	56.94	47.6	55.01	77.16	69.39
EBIT	298.16	183.84	88.4	79.68	50.02	32.58
EBIT Margin	16.10%	12.20%	6.95%	7.43%	4.99%	4.65%
Effective Tax Rate	14.76%	20.95%	24.19%	179.80%	-	60.37%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.